Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EPS (Weighted Average and Diluted) (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with -$0.64 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 46.22% to -$0.64 in Q4 2025 year-over-year; TTM through Oct 2025 was -$3.96, a 7.9% decrease, with the full-year FY2025 number at -$5.13, down 1.18% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.64 for Q4 2025 at Kestra Medical Technologies, down from -$0.5 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.18 in Q2 2024 to a low of -$1.57 in Q2 2025.